CLEVELAND, Ohio (WKRC) - The Cleveland Clinic has released the results from its breast cancer vaccine trial's first phase. According to a Cleveland Clinic-issued statement, researchers with the ...

The MarketWatch News Department was not involved in the creation of this content. SAN JOSE, Calif., Dec. 15, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a ...

Cleveland Clinic Innovations, the business development and commercialization arm of Cleveland Clinic, announced the creation of a spinoff company to develop a breast cancer vaccine. The company, ...

CLEVELAND — Measles cases in the U.S. are at their highest levels since 2000, and experts say lower vaccination rates here and around the world are driving the resurgence. 3News’ Senior Health ...

Chairman and CEO Dr. Amit Kumar said the company views 2026 as a “pivotal year” as it advances two clinical-stage programs: a breast cancer vaccine being developed with the Cleveland Clinic and the U.

SAN JOSE, Calif., Dec. 15, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. (ANIX) ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, ...